Topical Skincare (Cosmetic Serums and Creams) This is the most common, safest, and most accessible use
NAD+ supplements (typically NR or NMN) raise cellular coenzyme levels, whilst retatrutide is an unlicensed investigational triple receptor agonist (GLP-1, GIP, glucagon) not yet approved by the MHRA or EMA for use in the UK
Contrave combines two medications bupropion and naltrexone to reduce food cravings and help manage emotional eating
6.3 Integration with other cardioprotective therapies Given the expanding use of combined cardiometabolic treatments, it is essential to evaluate interactions between GLP-1RAs and statins, SGLT2 inhibitors, and PCSK9 inhibitors
Semaglutide should be started with a small dose of 0.25 mg in subcutaneous injection, jabbed once a week